Compare Medpace Holdings Inc (MEDP) vs Remitly Global Inc (RELY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Remitly Global Inc — how do they compare? Medpace Holdings Inc trades at $534.38 (market cap $15.08B), while Remitly Global Inc trades at $23.72 (market cap $5.02B). The key difference: Medpace Holdings Inc is far larger — about 3× Remitly Global Inc's market cap, and Remitly Global Inc is trading nearer its 52-week high, Medpace Holdings Inc nearer its low. Which is the better fit depends on your goals.
| MEDP | RELY | |
|---|---|---|
Market Cap | $15.08B | $5.02B |
Sector | Technology | Technology |
52-Week High | $620.59 | $25.23 |
52-Week Low | $308.88 | $12.20 |
Enterprise Value | $14.55B | $4.41B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
RELY trades at $23.84, down 1.2% on the day, with a bullish technical signal from moving averages and strong analyst consensus. The company shows accelerating revenue growth, reaching $1.64 billion in 2025, and achieved profitability with net income of $67.93 million. Recent news highlights expansion into the UAE market and positive earnings beats.
The outlook is positive, driven by market share gains in the remittance sector and raised 2026 guidance. Key risks include intense competition and execution challenges in international expansion. Wall Street sentiment is strongly bullish with a $27.40 price target, suggesting 15% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Remitly Global Inc
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
Read more on RELY →
